Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- BST.MC
- Price
- 0.20
- Stock movement up
- +0.01 (3.96%)
- Company name
- Biotechnology Assets S.A.
- Exchange
- (MC ,
- Currency
- EUR )
- Sector
- Healthcare >Biotechnology
- Market cap
- 14.05M
- Ent value
- 20.48M
- Price/Sales
- 2.88
- Price/Book
- 2.18
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -29.54%
- 1 year return (CAGR)
- -39.76%
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-01-22
DIVIDENDS
BST.MC does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | 25.90 |
| Price to FCF | 26.94 |
| Price to EBITDA | 42.64 |
| EV to EBITDA | 62.17 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 2.88 |
| Price to Book | 2.18 |
| EV to Sales | 4.20 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 71.31M |
| EPS (TTM) | -0.06 |
| FCF per share (TTM) | 0.01 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 4.88M |
| Gross profit (TTM) | 2.72M |
| Operating income (TTM) | -4.45M |
| Net income (TTM) | -4.37M |
| EPS (TTM) | -0.06 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 55.74% |
| Operating margin (TTM) | -91.19% |
| Profit margin (TTM) | -89.72% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 569.31K |
| Net receivables | 2.54M |
| Total current assets | 3.15M |
| Goodwill | 1.14M |
| Intangible assets | 3.78M |
| Property, plant and equipment | 0.00 |
| Total assets | 13.46M |
| Accounts payable | 193.01K |
| Short/Current long term debt | 4.59M |
| Total current liabilities | 3.10M |
| Total liabilities | 7.01M |
| Shareholder's equity | 6.45M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 542.33K |
| Capital expenditures (TTM) | 20.80K |
| Free cash flow (TTM) | 521.53K |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -67.79% |
| Return on Assets | -32.50% |
| Return on Invested Capital | -52.88% |
| Cash Return on Invested Capital | 6.31% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.19 |
| Daily high | 0.20 |
| Daily low | 0.19 |
| Daily Volume | 273K |
| All-time high | 13.40 |
| 1y analyst estimate | - |
| Beta | 2.24 |
| EPS (TTM) | -0.06 |
| Dividend per share | 0.00 |
| Ex-div date | 6 Jun 2022 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| BST.MC | S&P500 | |
| Current price drop from All-time high | -98.53% | -0.89% |
| Highest price drop | -98.64% | -19.00% |
| Date of highest drop | 7 Jan 2026 | 8 Apr 2025 |
| Avg drop from high | -97.57% | -2.49% |
| Avg time to new high | - | 6 days |
| Max time to new high | 328 days | 89 days |
COMPANY DETAILS
Marketcap
14.05M
Marketcap category
Small-cap
Description
Biotechnology Assets, S.A. develops and markets biotechnological assets for applications in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industries in Spain and internationally. It offers SPLITTERA, a protein engineering tool that allows the conjugation of proteins through the formation of new peptide bonds; universal switchable split-chimeric antigen receptor (CAR); VACC-ZERA technology, a tool to generate recombinant proteins in microparticles suited for therapeutic and prophylactic adjuvant free vaccines administered as DNA vaccines; and CLICK'N CUT, a tool to obtain tag-less proteins in a one-step process based on intein affinity, as well as Zebrafish assays. The company is based in Cádiz, Spain.
Employees
30
Website
Investor relations
-
SEC filings
CEO
Country
Spain
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found